PARP1 and Parkinson disease: Thus, using DX2 for selective inhibition of PARP-1 overactivation, only when AIMP2 accumulation is present, would be a smart strategy for treating PD effectively while avoiding unnecessary adverse effects due to the use of PARP inhibitors.